Abstract:Purpose A reliable locoregional recurrence (LRR) prediction model is important for the personalized management of head and neck cancers (HNC) patients who received radiotherapy. This work aims to develop a delta‐radiomics feature‐based multi‐classifier, multi‐objective, and multi‐modality (Delta‐mCOM) model for post‐treatment HNC LRR prediction. Furthermore, we aim to adopt a learning with rejection option (LRO) strategy to boost the reliability of Delta‐mCOM model by rejecting prediction for samples with high prediction uncertainties. Methods In this retrospective study, we collected PET/CT image and clinical data from 224 HNC patients who received radiotherapy (RT) at our institution. We calculated the differences between radiomics features extracted from PET/CT images acquired before and after radiotherapy and used them in conjunction with pre‐treatment radiomics features as the input features. Using clinical parameters, PET radiomics features, and CT radiomics features, we built and optimized three separate single‐modality models. We used multiple classifiers for model construction and employed sensitivity and specificity simultaneously as the training objectives for each of them. Then, for testing samples, we fused the output probabilities from all these single‐modality models to obtain the final output probabilities of the Delta‐mCOM model. In the LRO strategy, we estimated the epistemic and aleatoric uncertainties when predicting with a trained Delta‐mCOM model and identified patients associated with prediction of higher reliability (low uncertainty estimates). The epistemic and aleatoric uncertainties were estimated using an AutoEncoder‐style anomaly detection model and test‐time augmentation (TTA) with predictions made from the Delta‐mCOM model, respectively. Predictions with higher epistemic uncertainty or higher aleatoric uncertainty than given thresholds were deemed unreliable, and they were rejected before providing a final prediction. In this study, different thresholds corresponding to different low‐reliability prediction rejection ratios were applied. Their values are based on the estimated epistemic and aleatoric uncertainties distribution of the validation data. Results The Delta‐mCOM model performed significantly better than the single‐modality models, whether trained with pre‐, post‐treatment radiomics features or concatenated BaseLine and Delta‐Radiomics Features (BL‐DRFs). It was numerically superior to the PET and CT fused BL‐DRF model (nonstatistically significant). Using the LRO strategy for the Delta‐mCOM model, most of the evaluation metrics improved as the rejection ratio increased from 0% to around 25%. Utilizing both epistemic and aleatoric uncertainty for rejection yielded nonstatistically significant improved metrics compared to each alone at approximately a 25% rejection ratio. Metrics were significantly better than the no‐rejection method when the reject ratio was higher than 50%. Conclusions The inclusion of the delta‐radiomics feature improved the accuracy of HNC LRR prediction, and the proposed Delta‐mCOM model can give more reliable predictions by rejecting predictions for samples of high uncertainty using the LRO strategy. This article is protected by copyright. All rights reserved

A multi‐objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

Towards reliable head and neck cancers locoregional recurrence prediction using delta‐radiomics and learning with rejection option

Towards reliable head and neck cancers locoregional recurrence prediction using delta-radiomics and learning with rejection option

CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.

Application of a Comprehensive Model Based on CT Radiomics and Clinical Features for Postoperative Recurrence Risk Prediction in Non-small Cell Lung Cancer

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction

Multicenter Radio-Multiomic Analysis for Predicting Breast Cancer Outcome and Unravelling Imaging-Biological Connection

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma

Combining Many-objective Radiomics and 3-dimensional Convolutional Neural Network through Evidential Reasoning to Predict Lymph Node Metastasis in Head and Neck Cancer

Predicting Lymph Node Metastasis in Head and Neck Cancer by Combining Many-objective Radiomics and 3-dimensioal Convolutional Neural Network through Evidential Reasoning

Locoregional recurrence prediction in head & neck cancer based on multi-modality and multi-view feature expansion

Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma

Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics

Multiregional Radiomics Nomogram for Postoperative Recurrence Risk Stratification in Localized Clear Cell Renal Cell Carcinoma

Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer

Multifactorial cancer treatment outcome prediction through multifaceted radiomics

Preoperative computed tomography‐guided disease‐free survival prediction in gastric cancer: a multicenter radiomics study

Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data

Prognosis Prediction in Head and Neck Squamous Cell Carcinoma by Radiomics and Clinical Information

Machine Learning-Based Radiomics for Predicting Outcomes in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy